
Sign up to save your podcasts
Or
In this episode, we explore KarXT, a groundbreaking experimental antipsychotic that works through the cholinergic system rather than dopamine pathways. Could this novel approach revolutionize schizophrenia treatment by offering similar efficacy to current antipsychotics but without the motor side effects?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
4.6
267267 ratings
In this episode, we explore KarXT, a groundbreaking experimental antipsychotic that works through the cholinergic system rather than dopamine pathways. Could this novel approach revolutionize schizophrenia treatment by offering similar efficacy to current antipsychotics but without the motor side effects?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
75 Listeners
501 Listeners
152 Listeners
3,340 Listeners
158 Listeners
1,342 Listeners
719 Listeners
514 Listeners
574 Listeners
16 Listeners
472 Listeners
577 Listeners
723 Listeners
187 Listeners
138 Listeners